DOM PHARM OCEAN INDIEN : revenue, balance sheet and financial ratios

DOM PHARM OCEAN INDIEN is a French company founded 28 years ago, specialized in the sector Activités des agences de publicité. Based in NEUILLY-SUR-SEINE (92200), this company of category PME shows in 2024 a revenue of 6.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - DOM PHARM OCEAN INDIEN (SIREN 417656964)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 6 004 451 € 5 103 290 € 2 834 044 € 2 979 557 € 2 829 573 € 3 210 405 € 3 332 313 € 3 643 494 € 3 278 226 € 2 933 948 €
Net income 65 100 € 263 708 € 94 693 € 150 272 € 115 444 € 175 688 € 268 928 € 176 760 € 26 882 € 15 979 €
EBITDA -11 941 € 109 682 € -225 617 € -198 640 € -452 588 € -408 010 € -111 490 € 25 356 € -73 905 € -138 756 €
Net margin 1.1% 5.2% 3.3% 5.0% 4.1% 5.5% 8.1% 4.9% 0.8% 0.5%

Revenue and income statement

In 2024, DOM PHARM OCEAN INDIEN achieves revenue of 6.0 M€. Over the period 2015-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +8.3%. Vs 2023, growth of +18% (5.1 M€ -> 6.0 M€). After deducting consumption (0 €), gross margin stands at 6.0 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -12 k€, representing -0.2% of revenue. Warning negative scissor effect: despite revenue change (+18%), EBITDA varies by -111%, reducing margin by 2.3 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 65 k€, i.e. 1.1% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

6 004 451 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

6 004 451 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-11 941 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

99 434 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

65 100 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-0.2%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

44.143%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-2.487%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
DOM PHARM OCEAN INDIEN

Sector positioning

Debt ratio
0.0 2024
2022
2023
2024
Q1: 0.0
Med: 7.82
Q3: 44.59
Excellent

In 2024, the debt ratio of DOM PHARM OCEAN INDIEN (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
44.14% 2024
2022
2023
2024
Q1: 9.69%
Med: 34.27%
Q3: 59.15%
Good -8 pts over 3 years

In 2024, the financial autonomy of DOM PHARM OCEAN INDIEN (44.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.14 years
Excellent

In 2024, the repayment capacity of DOM PHARM OCEAN INDIEN (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 184.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

184.282

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
DOM PHARM OCEAN INDIEN

Sector positioning

Liquidity ratio
184.28 2024
2022
2023
2024
Q1: 128.85
Med: 206.6
Q3: 363.72
Average -7 pts over 3 years

In 2024, the liquidity ratio of DOM PHARM OCEAN INDIEN (184.28) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 2.56x
Average

In 2024, the interest coverage of DOM PHARM OCEAN INDIEN (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 83 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 89 days. Favorable situation: supplier credit is longer than customer credit by 6 days. Overall, WCR represents 77 days of revenue, i.e. 1.3 M€ to permanently finance. Over 2015-2024, WCR increased by +3177%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

1 285 613 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

83 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

89 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

77 j

WCR and payment terms evolution
DOM PHARM OCEAN INDIEN

Positioning of DOM PHARM OCEAN INDIEN in its sector

Comparison with sector Activités des agences de publicité

Valuation estimate

Based on 68 transactions of similar company sales (all years), the value of DOM PHARM OCEAN INDIEN is estimated at 884 510 € (range 371 575€ - 1 661 882€). The price/revenue ratio is 0.22x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
68 tx
371k€ 884k€ 1661k€
884 510 € Range: 371 575€ - 1 661 882€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

Revenue Multiple 30%
6 004 451 € × 0.22x
Estimation 1 347 770 €
558 588€ - 2 294 168€
Net Income Multiple 20%
65 100 € × 2.9x
Estimation 189 621 €
91 057€ - 713 455€
How is this estimate calculated?

This estimate is based on the analysis of 68 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des agences de publicité)

Compare DOM PHARM OCEAN INDIEN with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des agences de publicité

Frequently asked questions about DOM PHARM OCEAN INDIEN

What is the revenue of DOM PHARM OCEAN INDIEN ?

The revenue of DOM PHARM OCEAN INDIEN in 2024 is 6.0 M€.

Is DOM PHARM OCEAN INDIEN profitable?

Yes, DOM PHARM OCEAN INDIEN generated a net profit of 65 k€ in 2024.

Where is the headquarters of DOM PHARM OCEAN INDIEN ?

The headquarters of DOM PHARM OCEAN INDIEN is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.

Where to find the tax return of DOM PHARM OCEAN INDIEN ?

The tax return of DOM PHARM OCEAN INDIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does DOM PHARM OCEAN INDIEN operate?

DOM PHARM OCEAN INDIEN operates in the sector Activités des agences de publicité (NAF code 73.11Z). See the 'Sector positioning' section above to compare the company with its competitors.